The best thing about the stock market is that you can make money in�either direction. Historically, stock indexes have tended to trend up over the long term. But when you look at individual stocks, you'll find plenty that lose money over the long haul. According to hedge fund institution Blackstar Funds, even with dividends�included, between 1983 and 2006, 64% of stocks underperformed the Russell 3000, a broad-scope market index.
A large influx of short-sellers shouldn't be a condemning factor for any company, but it could be a red flag from traders that something may not be as cut-and-dried as it appears. Let's look at three companies that have seen a rapid increase in the number of shares sold short and see whether traders are blowing smoke or if their worry has some merit.
Company
Short Increase June 28 to July 15
Short Shares as a % of Float
VelocityShares Daily 2X VIX (NYSEMKT: TVIX )
Best Cheap Companies To Watch For 2015: Medizone International Inc (MZEI)
Medizone International, Inc. (Medizone), incorporated in January 31, 1986, is a development-stage company. The Company is engaged in research into the medical uses of ozone. Medizone focuses in the field of hospital sterilization. It is a research and development company engaged in developing its AsepticSure. The Company is developing an ozone-based technology (AsepticSure) for decontaminating and sterilizing hospital surgical suites, emergency rooms, and intensive care units.
The Company started hospital beta-testing of a prototype system utilizing the original technology. The first round of in-hospital beta-testing for this AsepticSure hospital disinfection system was completed at a Hotel Dieu hospital in Kingston, Ontario, Canada. In addition to the hospital disinfection system, it employs an ozone-destruct unit which is used following disinfection of the treated infrastructure to reverse the O3 gas in the space, and turn it back into O2 in a short period of time. The Company�� subsidiaries include Medizone Canada, Ltd. (MedCan). As of December 31, 2011, the Company had not generated any revenues.
Advisors' Opinion:- [By CRWE]
Today, MZEI surged (+5.64%) up +0.0048 at $.0899 with 21,900 shares in play thus far (ref. google finance Delayed: 1:32PM EDT October 16, 2013).
Medizone International, Inc. previously reported that its WHO award-winning green infection control technology, AsepticSure has been Granted a patent by the United States Patent and Trademark office. (US 61/223,219) titled “Healthcare Facility Disinfecting System”. The AsepticSure infection control system has repeatedly demonstrated 100% microbial kill rates when used to decontaminate hospital rooms of the causative agents of HAI (hospital acquired infections).
“With patent protection now established in the United States, Canada and Singapore and pending applications in process for the 37 member countries of the EU as well as Korea, Japan, China, India, Brazil and Mexico, our patent momentum is clearly gaining strength,” stated Edwin Marshall, Medizone’s CEO.
Top Long Term Stocks To Buy For 2014: Alliance Holdings GP L.P.(AHGP)
Alliance Holdings GP, L.P., through its subsidiaries, produces and markets coal primarily to utilities and industrial users in the United States. It produces a range of steam coal with varying sulfur and heat contents. The company operates nine underground mining complexes in Illinois, Indiana, Kentucky, Maryland, and West Virginia. As of December 31, 2010, it had approximately 697.4 million tons of proven and probable coal reserves in Illinois, Indiana, Kentucky, Maryland, Pennsylvania, and West Virginia. In addition, the company leases land; and operates a coal loading terminal, with a capacity of 8.0 million tons with ground storage of approximately 60,000 to 70,000 tons, on the Ohio River at Mt. Vernon, Indiana. Further, it engages in purchasing and selling coal; and providing services, including ash and scrubber sludge removal, coal yard maintenance, and arranging alternate transportation services. Alliance GP, LLC, serves as the general partner of the company. Allian ce Holdings GP, L.P. is based in Tulsa, Oklahoma.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Alliance Holdings GP (Nasdaq: AHGP ) , whose recent revenue and earnings are plotted below. - [By Robert Rapier]
The National Association of Publicly Traded Partnerships (NAPTP) lists five MLPs in the category ��atural Resources – Coal,��although two of the five are Alliance Holdings (NYSE: AHGP) and its operating affiliate, Alliance Resource Partners (NYSE: ARLP). The other three are Natural Resource Partners (NYSE: NRP), Rhino Resource Partners (NYSE: RNO), and Oxford Resource Partners (NYSE: OXF).
Top Long Term Stocks To Buy For 2014: Hellenic Sugar Industry SA (HSI)
Hellenic Sugar Industry SA is a Greece-based company engaged in the production and trade of white crystal sugar and its by-products, such as molasses and sugar beet seed. Its principal activities include the manufacture of all types of sweetener products and general kneading products; the production and processing of sugar beet and other plants; the production of raw materials for sugar production; the establishment, equipping and exploitation of sugar producing factories; conducting scientific research in all fields of activity of the Company; the trade and standardization of sugar products, by-products, raw materials, multiple materials, agricultural products and machinery, and carrying out agro-industrial activities in Greece and abroad. The Company has five sugar factories and one seed processing factory in Greece. Advisors' Opinion:- [By Emma O��rien]
Hong Kong�� Hang Seng Index (HSI) closed little changed, paring gains of as much as 0.7 percent. The gauge briefly erased this year�� losses this morning. Trading in the city resumed today after being canceled yesterday due to a typhoon. China�� Shanghai Composite Index dropped 0.9 percent.
- [By Eleni Himaras]
Australia�� S&P/ASX 200 Index (AS51) slipped 0.4 percent. Singapore�� Straits Times Index gained 0.2 percent and Taiwan�� Taiex Index retreated 0.4 percent. Hong Kong�� Hang Seng Index (HSI) slipped 0.1 percent after rising as much as 0.4 percent and China�� Shanghai Composite Index added 0.1 percent.
Top Long Term Stocks To Buy For 2014: Gem International Resources Inc (GI)
Gem International Resources Inc. (Gem International) is a Canada-based junior natural resource company. The Company is primarily engaged in the acquisition, exploration and development of mineral properties with its principal focus on diamond, gold and other precious metals. The Company is in exploration-stage and has interest in mineral properties located in Canada and Tanzania. The Company owns more than 105 mining claims comprised of approximately 240,172 acres located in the Lac de Gras Property located approximately 260 kilometers northeast of Yellowknife, Northwest Territories. Its Kolandoto Diamond Property is located in the Shinyanga region of Tanzania. Kolandoto property consists of approximately10 primary mining licenses covering a total area of approximately 247 acres. The Shinyanga Property consists of more than 105 primary mining licenses covering a total area of approximately 2,743 acres. Advisors' Opinion:- [By Victor Selva]
In January 2014, Forest acquired Toronto-based Aptalis, a privately held U.S.-based specialty Gastrointestinal (GI) and Cystic Fibrosis Company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The deal looks attractive especially keeping in mind the fact that Namenda will be facing generic competition from 2015. The acquisition will also give Forest the opportunity to build its presence in Europe and strengthen its GI and CF portfolios.
Top Long Term Stocks To Buy For 2014: CryoLife Inc (CRY)
CryoLife, Inc. (CryoLife,), incorporated in January 19,1984, is a biological medical device company. The Company preserves and distributes human tissues for transplantation and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve (CryoValve SGPV) and the CryoPatch SG pulmonary cardiac patch tissue (CryoPatch SG), both processed using CryoLife�� SynerGraft technology. The Company operates in two segments: preservation services and medical devices segment. The preservation services segment includes services revenues from the preservation of cardiac and vascular tissues during the year ended December 31, 2011. The medical devices segment includes revenues from product sales of BioGlue, BioFoam, PerClot, HemoStase and revascularization technologies, as well as sales of other medical devices. CryoLife�� surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam) and PerClot, an absorbable powdered hemostat. In May 2011, it acquired Cardiogenesis Corporation. In May 2012, the Company acquired Hemosphere, Inc. Hemosphere develops and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction. In February 2014, CryoLife Inc announced the establishment of CryoLife Asia Pacific Pte. Ltd.
CryoLife distributes preserved human cardiac and vascular tissues to implanting institutions throughout the United States (U.S), Canada and Europe. CryoLife processes and preserves cardiac and vascular tissues using processing and freezing techniques, or cryopreservation. The Company�� preservation process involves the recovery of tissue from deceased human donors by tissue banks and organ procurement organizations (OTPOs), the delivery, of such tissue to the Company, the s! creening, dissection, disinfection, processing, and preservation of the tissue by the Company, and the storage and shipment of the preserved tissue.
The human heart valves and cardiac patch tissues preserved by the Company are used in cardiac reconstruction and heart valve replacement surgeries. The Company preserves human aortic and pulmonary heart valves for implantation by cardiac surgeons. In addition, the Company preserves human cardiac patches for surgeons. The Company preserves human cardiac patches in three primarily anatomic configurations: pulmonary hemi-artery, pulmonary trunk and pulmonary branch. As of December 31, 2011, CryoLife shipped approximately 77,600 heart valves and cardiac patch tissues, including approximately 3,000 shipments during 2011.
The human vascular tissues preserved by the Company, including the CryoVein and CryoArtery, are used to treat a variety of vascular reconstructions, such as peripheral bypass, hemodialysis access and aortic infections. The Company preserves small diameter human saphenous vein conduits (3 millimeter to 6 millimeter) for use in peripheral vascular reconstructions. The Company also preserves femoral veins and arteries and aortoiliac arteries for bypass, hemodialysis access, or reconstruction within infected surgical areas. As of December 31, 2011, the Company shipped approximately 66,100 human vascular tissues, including approximately 4,500 shipments during 2011.
CryoLife�� product BioGlue, designed for cardiac, vascular, pulmonary, and general surgical applications, is a polymer based on bovine blood protein and an agent for cross-linking proteins. CryoLife distributes BioGlue throughout the United States and approximately 75 other countries. CryoLife distributes BioGlue for repair of soft tissues under conformite Europeene Mark Product Certification (CE Mark). CryoLife distributes BioGlue in Japan for use in the repair of aortic dissections.
CryoLife�� product, BioFoam, is a protein hydr! ogel biom! aterial with an expansion agent, which generates a mixed-cell foam. The foam creates a mechanical barrier to decrease blood flow and develops pores for the blood to enter, leading to cellular aggregation and enhanced hemostasis. CryoLife distributes BioFoam under CE Mark certification.
CryoLife�� product, PerClot, is an absorbable, powdered hemostatic agent used in surgery. PerClot particles have a molecular structure that absorbs water from blood, creating a high concentration of platelets, red blood cells, and coagulation proteins at the bleeding site, which accelerates the physiologic clotting cascade. PerClot is readily dissolved by saline irrigation and is totally absorbed within several days. PerClot is available in one gram, three gram and five gram sizes with a 100 millimeter or 200 millimeter applicator tip. PerClot Laparoscopic is available in one gram and three gram sizes with a 380 millimeter applicator tip.
The Company competes with St. Jude Medical, Inc., Medtronic, Inc., Edwards Life Sciences, Inc., Neovasc, Inc., LifeNet Health, Inc. W.L. Gore & Associates��Propaten, C.R. Bard, Inc., Hancock Jaffe Laboratories, Inc., Maquet, Inc., CorMatrix Cardiovascular, Inc., Baxter International, Inc., Johnson & Johnson Company, Covidien Ltd, NeoMend, Inc., Pfizer, Inc., Orthovita, Inc., King Pharmaceuticals, Inc., Ethicon, Inc., ZymoGenetics, Inc. and Nycomed.
Advisors' Opinion:- [By Eric Volkman]
CryoLife (NYSE: CRY ) is putting some zip into its shares with a dividend boost. The company has declared a fresh quarterly distribution of $0.0275 per share, to be paid on June 21 to shareholders of record as of June 14. This marks the company's first-ever dividend increase -- the new amount is 10% higher than its three prior (and only) payouts, each of which totaled $0.025.
Top Long Term Stocks To Buy For 2014: Taylor Capital Group Inc.(TAYC)
Taylor Capital Group, Inc. operates as the bank holding company for Cole Taylor Bank that provides a range of commercial banking products and services primarily to closely-held commercial customers and their owner operators in the Chicago area. It offers various deposit products, including checking, savings, and money market accounts, as well as time deposits, and other deposit and credit services to commercial clients and community-based customers, including individuals and small local businesses. The company?s commercial lending activities primarily consist of providing loans for working capital and business expansion or acquisition; owner-occupied commercial real estate financing; revolving lines of credit; and stand-by and commercial letters of credit. It also originates and sells mortgage loans. In addition, the company provides treasury cash management services, including repurchase agreements, Internet balance reporting, remote deposit capture, positive pay, automa ted clearing house products, imaged lock-box processing, controlled disbursement, and account reconciliation services to commercial clients; and investment management and brokerage services. Further, it offers asset-based financing, including revolving lines of credit supported by receivables and inventory; and term loans supported by equipment and real estate. The company?s target commercial lending customers include businesses engaged in various industries, such as manufacturing, wholesale and retail distribution, transportation, construction contracting, and professional services. It operates through nine banking centers in the Chicago area. The company was founded in 1929 and is headquartered in Rosemont, Illinois.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Taylor Capital (NASDAQ: TAYC ) , the holding company of Cole Taylor Bank, a commercial and consumer lending and financial services company located in the Chicago area, skyrocketed as much as 22% after agreeing to be purchased by MB Financial (NASDAQ: MBFI ) .
- [By Rich Duprey]
Commercial banking concern Taylor Capital Group (NASDAQ: TAYC ) announced yesterday its third-quarter dividend of $0.50 per share on its�Series A perpetual non-cumulative preferred stock, which trades on the Nasdaq exchange under the symbol TAYCO.
- [By Rich Duprey]
Looking to expand its banking business in the Windy City, MB Financial (NASDAQ: MBFI ) jointly announced with Taylor Capital (NASDAQ: TAYC ) that it was buying the�holding company of�Cole Taylor�Bank, a Chicago-based commercial bank with $5.9 billion in assets, $3.3 billion in loans, and $3.7 billion in deposits.
No comments:
Post a Comment